Improving Compliance With Medical Testing Guidelines

NCT ID: NCT02430948

Last Updated: 2019-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

218 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2017-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study hypothesis is that clearer visual presentation of guideline recommendations and educational outreach, or academic detailing, can improve guideline compliance. However, it will investigate other aspects of screening-related decision-making, such as provider and patient beliefs about screening, provider-patient communication and patient's willingness to forgo expected testing. The research question is whether educational interventions can decrease non-compliance with screening guidelines for 5 common cancers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a cluster randomized trial that compares the immediate post-encounter impressions of 12 physicians and 18 of their patients about the discussion of screening for breast, cervical, colorectal, lung and prostate cancer as well as their beliefs about screening efficacy and patient reports of the screening experience. The interventions are educational materials and academic detailing (educational outreach) for providers. The investigators are particularly interested in contrasting the patient and provider recollections, the differential impact on underuse and overuse compliance and whether patient behaviors are consistent with their stated screening plans.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Cervical Cancer Prostate Cancer Colon Cancer Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Support Outreach

Providers receive standard written screening recommendations and do not receive academic detailing (educational outreach)

Group Type ACTIVE_COMPARATOR

Standard support

Intervention Type OTHER

Screening recommendations presented in standard format

No academic detailing

Intervention Type OTHER

Physician receives study orientation for not the academic detailing curriculum

Standard materials and academic detailing

Providers receive standard written screening recommendations and receive academic detailing (educational outreach)

Group Type EXPERIMENTAL

Academic detailing

Intervention Type OTHER

Educational outreach to address the rationale and data supporting recommendations for and against screening

Standard support

Intervention Type OTHER

Screening recommendations presented in standard format

Color-coded materials and no academic detailing

Providers receive color-coded written screening recommendations and do not receive academic detailing (educational outreach)

Group Type EXPERIMENTAL

Color-coded materials

Intervention Type OTHER

A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation

No academic detailing

Intervention Type OTHER

Physician receives study orientation for not the academic detailing curriculum

Color-coded materials and academic detailing

Providers receive color-coded written screening recommendations and receive academic detailing (educational outreach)

Group Type EXPERIMENTAL

Color-coded materials

Intervention Type OTHER

A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation

Academic detailing

Intervention Type OTHER

Educational outreach to address the rationale and data supporting recommendations for and against screening

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Color-coded materials

A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation

Intervention Type OTHER

Academic detailing

Educational outreach to address the rationale and data supporting recommendations for and against screening

Intervention Type OTHER

Standard support

Screening recommendations presented in standard format

Intervention Type OTHER

No academic detailing

Physician receives study orientation for not the academic detailing curriculum

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients: healthy men and women ages 30-89 seeing their primary care provider for routine visit
* Providers: non-pediatric primary care physicians from Mount Sinai Beth Israel or St. Luke's-Roosevelt associated practices

Exclusion Criteria

* Patient life expectancy of less than 1 year in primary care provider's judgment
* Inability to read and understand English
* Transgender status
Minimum Eligible Age

30 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beth Israel Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James A Talcott, MD SM

Role: PRINCIPAL_INVESTIGATOR

Mount Sinai Beth Israel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mount Sinai Beth Israel

New York, New York, United States

Site Status

St. Luke's-Roosevelt

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OGARA CAN-264

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.